Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Baxter
Mallinckrodt
Cipla
US Department of Justice
Colorcon
Cerilliant
McKinsey

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,854,290

« Back to Dashboard

Summary for Patent: 5,854,290
Title: Use of guanfacine in the treatment of behavioral disorders
Abstract:Disclosed is a method of treating disorders which have prominent symptoms of behavioral disinhibition (e.g., Attention-Deficit Hyperactivity Disorder, Conduct Disorder, Oppositional Defiant Disorder, Tourette's Syndrome, Lesch-Nyhan Syndrome, or the disinhibitory symptoms accompanying Post-traumatic Stress Disorder or dementia) in a primate with minimal sedative side effects by administering thereto a therapeutically effective amount of guanfacine.
Inventor(s): Arnsten; Amy F. T. (Bethany, CT), Goldman-Rakic; Patricia S. (New Haven, CT), Hunt; Robert H. (Nashville, TN)
Assignee: Arnsten; Amy F. T. (Bethany, CT) Goldman-Rakic; Patricia (New Haven, CT) Hunt; Robert H. (Nashville, TN)
Application Number:08/531,643
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,854,290

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,854,290

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 6281298 ➤ Try a Free Trial
Israel 129460 ➤ Try a Free Trial
Japan 2001504811 ➤ Try a Free Trial
World Intellectual Property Organization (WIPO) 9816226 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Medtronic
Harvard Business School
Chubb
Queensland Health
Colorcon
US Department of Justice
Accenture
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.